Clinical Trial Update: Impella CP With VA ECMO for Cardiogenic Shock [NA]

View source ↗

Summary

This clinical trial update reports termination of a study evaluating Impella CP with VA ECMO for cardiogenic shock. Results for the trial have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Impella CP (Impella CP)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cardiogenic Shock | NA | Status: TERMINATED | Results posted: 2025-11-19